| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 5.59e-07 | 25 | 132 | 5 | GO:0017056 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | NCOA2 RBBP8 PHF12 ZMYND8 TRIM31 KDM3B MED1 SKI DDX1 NCOR2 TMF1 CTNNB1 TADA3 HCFC1 | 2.17e-05 | 562 | 132 | 14 | GO:0003712 |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 2.85e-05 | 27 | 132 | 4 | GO:0008139 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | NCOA2 SP1 RBBP8 ZMYND8 SRF PAGR1 MED1 SKI NCOR2 TMF1 CTNNB1 TADA3 HCFC1 | 1.30e-04 | 582 | 132 | 13 | GO:0140297 |
| GeneOntologyMolecularFunction | molecular adaptor activity | NCOA2 SP1 TCOF1 RBBP8 PHF12 ZMYND8 TRIM31 KDM3B SPAG9 TUT1 NUP62 MED1 SKI DDX1 NCOR2 PDE4DIP TMF1 MICAL3 CTNNB1 TADA3 HCFC1 | 2.20e-04 | 1356 | 132 | 21 | GO:0060090 |
| GeneOntologyMolecularFunction | nuclear receptor binding | 2.49e-04 | 187 | 132 | 7 | GO:0016922 | |
| GeneOntologyMolecularFunction | signal sequence binding | 3.58e-04 | 51 | 132 | 4 | GO:0005048 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 4.16e-04 | 53 | 132 | 4 | GO:0030331 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 4.60e-04 | 417 | 132 | 10 | GO:0061629 | |
| GeneOntologyMolecularFunction | transcription factor binding | NCOA2 SP1 RBBP8 PHF12 ZMYND8 SRF PAGR1 MED1 SKI NCOR2 TMF1 CTNNB1 TADA3 HCFC1 | 4.67e-04 | 753 | 132 | 14 | GO:0008134 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NCOA2 TCOF1 RBBP8 PHF12 ZMYND8 TRIM31 KDM3B SPAG9 TUT1 NUP62 MED1 SKI DDX1 NCOR2 TMF1 CTNNB1 TADA3 HCFC1 | 6.32e-04 | 1160 | 132 | 18 | GO:0030674 |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 7.11e-04 | 61 | 132 | 4 | GO:0030374 | |
| GeneOntologyMolecularFunction | chromatin binding | NCOA2 CENPB SRF KDM3B NUP62 MED1 SKI DDX1 NCOR2 MACROH2A2 CTNNB1 HCFC1 BAHCC1 | 1.24e-03 | 739 | 132 | 13 | GO:0003682 |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 1.99e-07 | 96 | 133 | 8 | GO:0006405 | |
| GeneOntologyBiologicalProcess | mRNA transport | 4.24e-07 | 145 | 133 | 9 | GO:0051028 | |
| GeneOntologyBiologicalProcess | RNA transport | 2.05e-06 | 175 | 133 | 9 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 2.05e-06 | 175 | 133 | 9 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 2.36e-06 | 178 | 133 | 9 | GO:0051236 | |
| GeneOntologyBiologicalProcess | nuclear export | 3.24e-06 | 185 | 133 | 9 | GO:0051168 | |
| GeneOntologyBiologicalProcess | RNA localization | 1.18e-05 | 217 | 133 | 9 | GO:0006403 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 3.49e-05 | 249 | 133 | 9 | GO:0015931 | |
| GeneOntologyBiologicalProcess | hematopoietic progenitor cell differentiation | 4.25e-05 | 197 | 133 | 8 | GO:0002244 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 6.66e-05 | 155 | 133 | 7 | GO:0043401 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | ZMYND8 TRIM31 SRF ARHGEF18 NUP62 SRCIN1 PLEKHG2 DNAJC6 ASAP1 PTPN13 EFNB1 AMIGO3 SLF2 ANLN PDE4DIP ELAPOR1 NAV3 CTNNB1 HCFC1 SLX4 | 7.57e-05 | 1189 | 133 | 20 | GO:0044087 |
| GeneOntologyBiologicalProcess | cell division | ERCC6L RBBP8 NUP62 SPECC1L THOC2 NSUN2 BIRC6 CEP164 LIG3 ANLN GOLGA8B DCLRE1A MICAL3 TADA3 | 1.67e-04 | 697 | 133 | 14 | GO:0051301 |
| GeneOntologyBiologicalProcess | nuclear transport | RGPD2 NUP62 NUP214 MED1 THOC2 POM121C NSUN2 POM121 SMG7 POM121B | 1.74e-04 | 378 | 133 | 10 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | RGPD2 NUP62 NUP214 MED1 THOC2 POM121C NSUN2 POM121 SMG7 POM121B | 1.74e-04 | 378 | 133 | 10 | GO:0006913 |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 1.88e-04 | 244 | 133 | 8 | GO:0009755 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular steroid hormone receptor signaling pathway | 1.99e-04 | 18 | 133 | 3 | GO:0033145 | |
| GeneOntologyBiologicalProcess | nuclear pore organization | 1.99e-04 | 18 | 133 | 3 | GO:0006999 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 2.54e-04 | 136 | 133 | 6 | GO:0030518 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 2.58e-04 | 324 | 133 | 9 | GO:0006302 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 2.76e-04 | 195 | 133 | 7 | GO:0006606 | |
| GeneOntologyBiologicalProcess | import into nucleus | 3.32e-04 | 201 | 133 | 7 | GO:0051170 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 3.42e-04 | 202 | 133 | 7 | GO:0141193 | |
| GeneOntologyCellularComponent | transcription repressor complex | 1.52e-06 | 87 | 135 | 7 | GO:0017053 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NCOA2 RGPD2 ERCC5 RBBP8 PHF12 KDM3B TUT1 NUP62 NUP214 PAGR1 MED1 THOC2 POM121C LIG3 NCOR2 POM121 SMG7 BICRAL CTNNB1 POM121B TADA3 HCFC1 SLX4 | 2.36e-05 | 1377 | 135 | 23 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear pore | 4.97e-05 | 101 | 135 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | nuclear envelope | RGPD2 GGN NUP62 NUP214 POM121C CLCC1 DES POM121 PGRMC2 NAV3 PHLPP1 CTNNB1 POM121B | 7.06e-05 | 560 | 135 | 13 | GO:0005635 |
| GeneOntologyCellularComponent | nuclear membrane | 4.50e-04 | 349 | 135 | 9 | GO:0031965 | |
| GeneOntologyCellularComponent | transcription regulator complex | NCOA2 SP1 RBBP8 PHF12 TEAD4 MED1 SKI LIN9 NCOR2 CTNNB1 SNAPC4 TADA3 | 4.94e-04 | 596 | 135 | 12 | GO:0005667 |
| MousePheno | abnormal cranial neural crest cell migration | 1.58e-05 | 7 | 109 | 3 | MP:0012757 | |
| MousePheno | abnormal frontal bone morphology | 2.96e-05 | 77 | 109 | 6 | MP:0000107 | |
| Domain | CH | 7.71e-05 | 65 | 126 | 5 | SM00033 | |
| Domain | CH | 1.10e-04 | 70 | 126 | 5 | PF00307 | |
| Domain | - | 1.18e-04 | 71 | 126 | 5 | 1.10.418.10 | |
| Domain | CH | 1.34e-04 | 73 | 126 | 5 | PS50021 | |
| Domain | CH-domain | 1.53e-04 | 75 | 126 | 5 | IPR001715 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 2.24e-07 | 40 | 93 | 6 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.61e-07 | 41 | 93 | 6 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 3.03e-07 | 42 | 93 | 6 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 3.51e-07 | 43 | 93 | 6 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 6.05e-07 | 47 | 93 | 6 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 7.79e-07 | 49 | 93 | 6 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 8.81e-07 | 50 | 93 | 6 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 9.93e-07 | 51 | 93 | 6 | MM15151 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.52e-06 | 86 | 93 | 7 | MM15413 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.57e-06 | 55 | 93 | 6 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 2.15e-06 | 58 | 93 | 6 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 2.15e-06 | 58 | 93 | 6 | MM14736 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 4.23e-06 | 65 | 93 | 6 | MM15147 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 8.36e-06 | 73 | 93 | 6 | MM14948 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 1.00e-05 | 114 | 93 | 7 | MM15361 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.64e-05 | 82 | 93 | 6 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.88e-05 | 84 | 93 | 6 | MM14929 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 3.17e-05 | 92 | 93 | 6 | MM14951 | |
| Pathway | REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS | 4.24e-05 | 59 | 93 | 5 | M27606 | |
| Pathway | PID_AR_PATHWAY | 4.98e-05 | 61 | 93 | 5 | M58 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 5.54e-05 | 32 | 93 | 4 | M29579 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 6.27e-05 | 33 | 93 | 4 | M27016 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 7.07e-05 | 34 | 93 | 4 | M27041 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 7.95e-05 | 35 | 93 | 4 | M27320 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 8.90e-05 | 36 | 93 | 4 | M26974 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 8.90e-05 | 36 | 93 | 4 | M27245 | |
| Pathway | REACTOME_TRNA_PROCESSING | 9.09e-05 | 111 | 93 | 6 | M27684 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 9.92e-05 | 37 | 93 | 4 | M1029 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 9.92e-05 | 37 | 93 | 4 | M27038 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | RGPD2 SP1 RBBP8 NUP62 NUP214 PAGR1 TEAD4 MED1 SKI THOC2 POM121C NCOR2 POM121 CTNNB1 SNAPC4 POM121B TADA3 HCFC1 | 1.06e-04 | 1022 | 93 | 18 | MM15436 |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.22e-04 | 39 | 93 | 4 | M27238 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 1.49e-04 | 41 | 93 | 4 | M29574 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.80e-04 | 43 | 93 | 4 | M26975 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 1.97e-04 | 44 | 93 | 4 | M109 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 2.11e-04 | 18 | 93 | 3 | MM15034 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 2.30e-04 | 84 | 93 | 5 | M725 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.34e-04 | 46 | 93 | 4 | M27397 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 2.55e-04 | 47 | 93 | 4 | M27395 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | NCOA2 RGPD2 ERCC6L SRF ARHGEF18 PLEKHG2 PTPN13 ANLN PGRMC2 GOLGA8B CTNNB1 ARHGAP45 PLXNB1 | 3.22e-04 | 649 | 93 | 13 | MM15690 |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 4.06e-04 | 53 | 93 | 4 | M27212 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 4.36e-04 | 54 | 93 | 4 | M29594 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 4.83e-04 | 277 | 93 | 8 | MM15414 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 5.09e-04 | 24 | 93 | 3 | MM15658 | |
| Pathway | REACTOME_SUMOYLATION | 8.75e-04 | 169 | 93 | 6 | MM14919 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA | 9.92e-04 | 30 | 93 | 3 | M47752 | |
| Pathway | REACTOME_M_PHASE | RGPD2 ERCC6L NUP62 NUP214 POM121C CEP164 POM121 GOLGA8B POM121B | 1.02e-03 | 387 | 93 | 9 | MM15364 |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 1.23e-03 | 71 | 93 | 4 | M27394 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 1.44e-03 | 74 | 93 | 4 | M48006 | |
| Pathway | REACTOME_SUMOYLATION | 1.56e-03 | 189 | 93 | 6 | M27214 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.66e-03 | 77 | 93 | 4 | MM14670 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.66e-03 | 77 | 93 | 4 | M27226 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | NCOA2 RGPD2 NUP62 NUP214 MED1 POM121C NCOR2 POM121 PGRMC2 POM121B | 1.79e-03 | 505 | 93 | 10 | MM15548 |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 1.98e-03 | 38 | 93 | 3 | MM17073 | |
| Pathway | WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR | 2.00e-03 | 81 | 93 | 4 | M39490 | |
| Pathway | REACTOME_CELL_CYCLE | RGPD2 ERCC6L RBBP8 NUP62 NUP214 POM121C LIN9 CEP164 POM121 GOLGA8B POM121B | 2.02e-03 | 603 | 93 | 11 | MM14635 |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 2.08e-03 | 271 | 93 | 7 | MM15406 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.10e-03 | 82 | 93 | 4 | M27250 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 2.14e-03 | 39 | 93 | 3 | MM14496 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 2.18e-03 | 138 | 93 | 5 | M29805 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | RGPD2 DDX52 WDR70 NUP62 NUP214 EDC4 THOC2 POM121C POM121 SMG7 POM121B | 2.27e-03 | 612 | 93 | 11 | MM15547 |
| Pathway | BIOCARTA_NPC_PATHWAY | 2.28e-03 | 11 | 93 | 2 | M22033 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 2.39e-03 | 85 | 93 | 4 | M1870 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 2.47e-03 | 41 | 93 | 3 | MM14876 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 2.65e-03 | 42 | 93 | 3 | M48018 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 2.65e-03 | 42 | 93 | 3 | M27172 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_EXPRESSION_AND_FUNCTION | 2.72e-03 | 12 | 93 | 2 | MM17071 | |
| Pathway | REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ | 2.72e-03 | 12 | 93 | 2 | M27569 | |
| Pathway | REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ | 2.72e-03 | 12 | 93 | 2 | MM15282 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | NCOA2 TLK2 ERCC6L CDKN2AIP WDR70 KDM3B SPAG9 MED1 LIG3 NCOR2 SLF2 ANLN AHNAK ZBTB21 SLTM HCFC1 SLX4 | 3.09e-12 | 444 | 139 | 17 | 34795231 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ERCC6L TCOF1 CDKN2AIP WDR70 ZMYND8 KDM3B SPAG9 NUP62 NUP214 EDC4 MED1 THOC2 POM121C NSUN2 RTN1 LIG3 PTPN13 SMG7 AHNAK PGRMC2 ZBTB21 UTRN HCFC1 | 3.25e-12 | 934 | 139 | 23 | 33916271 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TLK2 SP1 ERCC5 ERCC6L TCOF1 RBBP8 PHF12 ZMYND8 KDM3B SPAG9 NUP214 PAGR1 MED1 THOC2 NSUN2 NCOR2 ANLN ZBTB21 MICAL3 SNAPC4 MN1 | 5.18e-12 | 774 | 139 | 21 | 15302935 |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA2 HYOU1 SOBP PHF12 C15orf39 NUP214 PAGR1 SKI POM121C LIN9 LIG3 NCOR2 CTNNB1 SLX4 BAHCC1 | 1.34e-11 | 351 | 139 | 15 | 38297188 |
| Pubmed | 1.78e-11 | 15 | 139 | 6 | 14697343 | ||
| Pubmed | RGPD2 RBBP8 PHF12 ZMYND8 C15orf39 NUP214 BIRC6 LIN9 NCOR2 PTPN13 AHNAK ZBTB21 TMF1 UTRN S100PBP | 1.55e-10 | 418 | 139 | 15 | 34709266 | |
| Pubmed | NCOA2 SP1 SOBP DDX52 PHF12 ZMYND8 C15orf39 SPAG9 NUP62 NUP214 PAGR1 EDC4 SKI POM121C NSUN2 LIN9 DDX1 LIG3 NCOR2 SMG7 ZBTB21 TADA3 HCFC1 SLX4 SP7 | 4.84e-10 | 1429 | 139 | 25 | 35140242 | |
| Pubmed | NCOA2 ERCC6L TCOF1 KDM3B SPAG9 SPECC1L TEAD4 EDC4 MED1 THOC2 PTPN13 SMG7 ANLN AHNAK PGRMC2 HCFC1 | 7.59e-10 | 549 | 139 | 16 | 38280479 | |
| Pubmed | HYOU1 CDKN2AIP KIAA1549 RNF213 SPAG9 BIRC6 PABIR2 CLCC1 ASAP1 NCOR2 PTPN13 SMG7 PTPRZ1 AHNAK PGRMC2 SLTM TMF1 PHLPP1 MICAL3 MACROH2A2 UTRN | 1.33e-09 | 1049 | 139 | 21 | 27880917 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HYOU1 TCOF1 DDX52 NUP62 NUP214 SPECC1L EDC4 THOC2 NSUN2 DDX1 LIG3 POM121 EFNB1 AHNAK PGRMC2 ZBTB21 SLTM MACROH2A2 CTNNB1 UTRN | 5.17e-09 | 1024 | 139 | 20 | 24711643 |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 9.08e-09 | 38 | 139 | 6 | 12791264 | |
| Pubmed | NCOA2 PHF12 ZMYND8 KDM3B PAGR1 MED1 SKI LIN9 ANLN ZBTB21 HCFC1 | 1.21e-08 | 268 | 139 | 11 | 33640491 | |
| Pubmed | NCOA2 TLK2 HYOU1 PHF12 CDKN2AIP ZMYND8 KDM3B C15orf39 EDC4 MED1 THOC2 NSUN2 LIN9 DDX1 NCOR2 ANLN ZBTB21 BICRAL TADA3 HCFC1 | 1.78e-08 | 1103 | 139 | 20 | 34189442 | |
| Pubmed | PITPNM2 PHF12 SRRM4 KDM3B KIAA1549 SRCIN1 ADGRV1 TRANK1 SMG7 AMIGO3 RALGPS1 ZBTB21 NAV2 PLXNB1 | 3.09e-08 | 529 | 139 | 14 | 14621295 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 3.72e-08 | 123 | 139 | 8 | 26912792 | |
| Pubmed | HYOU1 ERCC6L WDR70 KDM3B ARHGEF18 RNF213 NUP214 BIRC6 RTN1 CLCC1 ANLN PGRMC2 TMF1 DCLRE1A CTNNB1 HCFC1 | 4.41e-08 | 733 | 139 | 16 | 34672954 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SP1 TCOF1 DDX52 PHF12 ZMYND8 NUP62 NUP214 PAGR1 MED1 SKI THOC2 POM121C LIN9 LIG3 NCOR2 SLF2 AHNAK SLTM DCLRE1A TADA3 HCFC1 | 5.03e-08 | 1294 | 139 | 21 | 30804502 |
| Pubmed | POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation. | 6.25e-08 | 3 | 139 | 3 | 30802453 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 35507432 | ||
| Pubmed | CENPB CDKN2AIP WDR70 ZMYND8 KDM3B RNF213 MED1 THOC2 NSUN2 DDX1 LIG3 NCOR2 AHNAK ZBTB21 SLTM CTNNB1 TADA3 HCFC1 | 1.34e-07 | 1014 | 139 | 18 | 32416067 | |
| Pubmed | Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes. | 2.49e-07 | 4 | 139 | 3 | 17900573 | |
| Pubmed | RBBP8 PHF12 SPECC1L MED1 THOC2 NSUN2 LIG3 SLF2 ANLN DCLRE1A TADA3 SLX4 | 3.09e-07 | 453 | 139 | 12 | 29656893 | |
| Pubmed | NCOA2 SPAG9 EDC4 MED1 THOC2 LIN9 FAM111B LIG3 ANLN AHNAK SLTM MICAL3 MACROH2A2 UTRN | 3.45e-07 | 645 | 139 | 14 | 25281560 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NCOA2 CENPB DDX52 WDR70 ZMYND8 SPAG9 SKI LIN9 DES LIG3 NCOR2 ZBTB21 TMF1 MACROH2A2 CTNNB1 HCFC1 | 3.62e-07 | 857 | 139 | 16 | 25609649 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ERCC6L KDM3B NUP62 PLEKHG2 EDC4 PABIR2 DDX1 C6orf132 ARFGEF3 PTPN13 SLF2 ANLN AHNAK ZBTB21 NAV2 UTRN | 3.86e-07 | 861 | 139 | 16 | 36931259 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PITPNM2 PHF12 WDR70 KDM3B C15orf39 NUP214 EDC4 POM121C BIRC6 C6orf132 NCOR2 RALGPS1 AHNAK NAV2 MICAL3 SNAPC4 HCFC1 BAHCC1 | 4.71e-07 | 1105 | 139 | 18 | 35748872 |
| Pubmed | FAT4 TCOF1 KDM3B RNF213 SPAG9 SPECC1L BIRC6 CLCC1 ARFGEF3 PTPN13 EFNB1 SLC30A5 AHNAK TMF1 DCLRE1A | 5.67e-07 | 777 | 139 | 15 | 35844135 | |
| Pubmed | HYOU1 CDKN2AIP WDR70 SPAG9 NUP62 NUP214 POM121C PABIR2 CLCC1 DDX1 PTPN13 POM121 EFNB1 SLC30A5 PGRMC2 TMF1 MAP7D2 | 6.18e-07 | 1007 | 139 | 17 | 34597346 | |
| Pubmed | 6.21e-07 | 5 | 139 | 3 | 14593076 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 9.85e-07 | 332 | 139 | 10 | 32786267 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | HYOU1 ERCC6L TCOF1 DDX52 NUP214 EDC4 POM121C NSUN2 RTN1 CLCC1 DDX1 ARFGEF3 POM121 ABCB10 PGRMC2 CTNNB1 | 1.25e-06 | 942 | 139 | 16 | 31073040 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | TCOF1 RBBP8 ZMYND8 KDM3B RNF213 EDC4 MED1 POM121C LIG3 HCFC1 | 1.25e-06 | 341 | 139 | 10 | 32971831 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SP1 TCOF1 ZMYND8 DDN ARHGEF18 NUP214 POM121C ASAP1 C6orf132 NCOR2 POM121 | 1.38e-06 | 430 | 139 | 11 | 35044719 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CDKN2AIP ZMYND8 NUP62 NUP214 MED1 THOC2 DDX1 LIG3 NCOR2 SLF2 ANLN AHNAK SLTM TADA3 HCFC1 SLX4 | 1.47e-06 | 954 | 139 | 16 | 36373674 |
| Pubmed | NCOA2 TLK2 RGPD2 TCOF1 CNTNAP1 DDN ARHGEF18 SPECC1L EDC4 DNAJC6 RTN1 NCOR2 PDE4DIP ZBTB21 GOLGA8B CTNNB1 | 1.66e-06 | 963 | 139 | 16 | 28671696 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NCOA2 PITPNM2 SOBP WDR70 SRF ARHGEF18 RNF213 SRCIN1 ADGRV1 SKI CLCC1 ARFGEF3 NCOR2 PTPN13 SMG7 RALGPS1 MICAL3 MACROH2A2 UTRN PDZD2 | 2.07e-06 | 1489 | 139 | 20 | 28611215 |
| Pubmed | HYOU1 ERCC6L KDM3B C15orf39 NSUN2 DDX1 FAM111B LIG3 SLC30A5 SLTM MICAL3 HCFC1 PLXNB1 | 2.28e-06 | 650 | 139 | 13 | 38777146 | |
| Pubmed | HYOU1 TCOF1 DDX52 SPAG9 NUP214 EDC4 THOC2 NSUN2 BIRC6 AHNAK SLTM UTRN HCFC1 | 2.40e-06 | 653 | 139 | 13 | 22586326 | |
| Pubmed | CENPB TCOF1 DDX52 PHF12 ZMYND8 KIAA1549 RNF213 SKI POM121C NCOR2 SMG7 ZBTB21 MACROH2A2 BICRAL TADA3 CDH16 BAHCC1 | 2.49e-06 | 1116 | 139 | 17 | 31753913 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | SRCIN1 NUP214 ASAP1 C6orf132 ANLN AHNAK PGRMC2 NAV2 GOLGA8B CTNNB1 UTRN HCFC1 | 3.09e-06 | 565 | 139 | 12 | 25468996 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 3.12e-06 | 220 | 139 | 8 | 35785414 | |
| Pubmed | 3.34e-06 | 222 | 139 | 8 | 37071664 | ||
| Pubmed | 3.45e-06 | 8 | 139 | 3 | 23178929 | ||
| Pubmed | SP1 NUP214 SPECC1L POM121C ASAP1 DES POM121 NAV3 NAV2 BICRAL CPLANE1 | 4.45e-06 | 486 | 139 | 11 | 20936779 | |
| Pubmed | PITPNM2 PDE1C HYOU1 CNTNAP1 KIAA1549 SRCIN1 SPECC1L EDC4 DNAJC6 RTN1 DDX1 ASAP1 PTPRZ1 PDE4DIP MAP7D2 MICAL3 CTNNB1 UTRN MTUS2 | 4.52e-06 | 1431 | 139 | 19 | 37142655 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | NCOA2 TCOF1 RBBP8 C15orf39 DDX1 FAM111B ARFGEF3 NCOR2 SMG7 SLF2 CTNNB1 SLX4 | 4.64e-06 | 588 | 139 | 12 | 38580884 |
| Pubmed | 4.64e-06 | 28 | 139 | 4 | 24880616 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CDKN2AIP ZMYND8 SRCIN1 NUP214 NSUN7 TRANK1 NAV2 MICAL3 ADGRF3 MUC4 HCFC1 | 5.49e-06 | 497 | 139 | 11 | 36774506 |
| Pubmed | DDN SPOCK2 NUP214 DNAJC6 ASAP1 ARFGEF3 PDE4DIP NAV3 MICAL3 PDZD2 | 6.02e-06 | 407 | 139 | 10 | 12693553 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | CDKN2AIP NUP62 MED1 LIN9 DDX1 NCOR2 ZBTB21 SLTM MACROH2A2 HCFC1 | 6.55e-06 | 411 | 139 | 10 | 35182466 |
| Pubmed | NCOA2 TLK2 ERCC5 HYOU1 DDX52 ARHGEF18 SPOCK2 THOC2 ASAP1 PTPN13 ANLN SLTM CPLANE1 UTRN SLX4 PLXNB1 | 7.45e-06 | 1084 | 139 | 16 | 11544199 | |
| Pubmed | 7.61e-06 | 177 | 139 | 7 | 26206133 | ||
| Pubmed | 9.64e-06 | 121 | 139 | 6 | 22412018 | ||
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 1.01e-05 | 11 | 139 | 3 | 9655502 | |
| Pubmed | NCOA2 SP1 FAT4 ERCC6L PHF12 KDM3B MED1 POM121C LIG3 NCOR2 MACROH2A2 ARHGAP45 | 1.05e-05 | 638 | 139 | 12 | 31182584 | |
| Pubmed | 1.15e-05 | 263 | 139 | 8 | 34702444 | ||
| Pubmed | 1.25e-05 | 191 | 139 | 7 | 20195357 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.43e-05 | 271 | 139 | 8 | 32433965 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | KDM3B RNF213 POM121C ARFGEF3 TRANK1 AHNAK PDE4DIP NAV2 MICAL3 CPLANE1 UTRN | 1.46e-05 | 552 | 139 | 11 | 10737800 |
| Pubmed | Probing nuclear pore complex architecture with proximity-dependent biotinylation. | 1.49e-05 | 77 | 139 | 5 | 24927568 | |
| Pubmed | CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma. | 1.59e-05 | 2 | 139 | 2 | 27829235 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 26496941 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 28322791 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 24374017 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22558357 | ||
| Pubmed | A Reciprocal Interaction between β-Catenin and Osterix in Cementogenesis. | 1.59e-05 | 2 | 139 | 2 | 28811640 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 29124436 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 34067464 | ||
| Pubmed | SLC13A3 is a major effector downstream of activated β-catenin in liver cancer pathogenesis. | 1.59e-05 | 2 | 139 | 2 | 39215042 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 21820092 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 26429915 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 34289528 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 26344907 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 9407313 | ||
| Pubmed | Variants in HCFC1 and MN1 genes causing intellectual disability in two Pakistani families. | 1.59e-05 | 2 | 139 | 2 | 38956580 | |
| Pubmed | Intron-less processed Pcdhalpha genes in the central nervous system. | 1.59e-05 | 2 | 139 | 2 | 14697259 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 11997063 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 32504044 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 26526617 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 37013185 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NCOA2 WDR70 NUP62 NUP214 TEAD4 POM121C DDX1 NCOR2 POM121 SMG7 | 1.64e-05 | 457 | 139 | 10 | 32344865 |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 1.73e-05 | 134 | 139 | 6 | 25452129 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.86e-05 | 281 | 139 | 8 | 28706196 | |
| Pubmed | Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair. | 2.41e-05 | 85 | 139 | 5 | 19596235 | |
| Pubmed | 2.69e-05 | 87 | 139 | 5 | 12465718 | ||
| Pubmed | 2.74e-05 | 15 | 139 | 3 | 15640798 | ||
| Pubmed | ARHGEF18 RNF213 SPAG9 POM121C BIRC6 POM121 ELAPOR1 MICAL3 POM121B SLX4 | 3.12e-05 | 493 | 139 | 10 | 15368895 | |
| Pubmed | Periaxin is required for hexagonal geometry and membrane organization of mature lens fibers. | 3.37e-05 | 16 | 139 | 3 | 21745462 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 3.41e-05 | 398 | 139 | 9 | 35016035 | |
| Pubmed | 3.51e-05 | 152 | 139 | 6 | 38360978 | ||
| Pubmed | 3.58e-05 | 225 | 139 | 7 | 12168954 | ||
| Pubmed | 4.08e-05 | 17 | 139 | 3 | 29911975 | ||
| Pubmed | 4.08e-05 | 17 | 139 | 3 | 19183483 | ||
| Pubmed | Sequence and evolution of the human germline V lambda repertoire. | 4.50e-05 | 49 | 139 | 4 | 8951372 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 10478845 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 37169737 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 32366234 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 23159876 | ||
| Pubmed | Regulation of Egr-1, SRF, and Sp1 mRNA expression in contracting skeletal muscle cells. | 4.75e-05 | 3 | 139 | 2 | 15310743 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 24735796 | ||
| Interaction | NAA40 interactions | ERCC6L TCOF1 CDKN2AIP WDR70 ZMYND8 KDM3B SPAG9 NUP62 NUP214 EDC4 MED1 THOC2 POM121C NSUN2 RTN1 LIG3 PTPN13 SMG7 AHNAK PGRMC2 ZBTB21 UTRN HCFC1 | 1.36e-07 | 978 | 135 | 23 | int:NAA40 |
| Interaction | NUP43 interactions | ERCC5 RBBP8 PHF12 CDKN2AIP ZMYND8 MUC19 CCDC168 NUP62 NUP214 POM121C LIG3 NCOR2 POM121 SLF2 TADA3 HCFC1 SLX4 PDZD2 | 2.00e-07 | 625 | 135 | 18 | int:NUP43 |
| Interaction | RCOR1 interactions | SP1 RBBP8 PHF12 ZMYND8 C15orf39 SPAG9 DNAJC6 BIRC6 NCOR2 PTPN13 AHNAK ZBTB21 TMF1 UTRN SP7 S100PBP | 2.11e-07 | 494 | 135 | 16 | int:RCOR1 |
| Interaction | PML interactions | NCOA2 TLK2 SP1 ERCC6L WDR70 SRF KDM3B RNF213 SPAG9 MED1 SKI THOC2 LIG3 NCOR2 SLF2 ANLN AHNAK SLTM MACROH2A2 CTNNB1 HCFC1 SLX4 | 2.53e-07 | 933 | 135 | 22 | int:PML |
| Interaction | KDM1A interactions | RBBP8 PHF12 ZMYND8 C15orf39 NUP214 THOC2 DNAJC6 BIRC6 LIN9 DDX1 NCOR2 PTPN13 SMG7 AHNAK PDE4DIP ZBTB21 TMF1 CTNNB1 TADA3 UTRN SP7 S100PBP | 2.93e-07 | 941 | 135 | 22 | int:KDM1A |
| Interaction | HDAC1 interactions | SP1 RBBP8 PHF12 ZMYND8 C15orf39 SPAG9 NUP214 DNAJC6 BIRC6 LIN9 DDX1 NCOR2 PTPN13 ANLN AHNAK ZBTB21 TMF1 PHLPP1 CTNNB1 UTRN HCFC1 BAHCC1 S100PBP | 1.21e-06 | 1108 | 135 | 23 | int:HDAC1 |
| Interaction | EGR2 interactions | NCOA2 PHF12 C15orf39 PAGR1 NCOR2 PDE4DIP CTNNB1 HCFC1 BAHCC1 | 2.31e-06 | 171 | 135 | 9 | int:EGR2 |
| Interaction | HNF4A interactions | NCOA2 SP1 PHF12 MUC19 PAGR1 MED1 LIN9 NCOR2 ZBTB21 CTNNB1 SLX4 | 2.51e-06 | 275 | 135 | 11 | int:HNF4A |
| Interaction | BRCA1 interactions | NCOA2 SP1 ERCC5 HYOU1 CENPB TCOF1 GGN RBBP8 PHF12 CDKN2AIP SPAG9 NUP214 DDX1 DES POM121 SMG7 SLF2 ANLN AHNAK DCLRE1A CTNNB1 HCFC1 SLX4 SP7 | 2.65e-06 | 1249 | 135 | 24 | int:BRCA1 |
| Interaction | RARA interactions | 2.65e-06 | 223 | 135 | 10 | int:RARA | |
| Interaction | PHF21A interactions | RBBP8 PHF12 ZMYND8 C15orf39 NUP62 NUP214 BIRC6 PTPN13 AHNAK TMF1 UTRN S100PBP | 3.46e-06 | 343 | 135 | 12 | int:PHF21A |
| Interaction | NCOA6 interactions | 6.07e-06 | 145 | 135 | 8 | int:NCOA6 | |
| Interaction | AR interactions | NCOA2 SP1 PHF12 ZMYND8 KDM3B RNF213 PAGR1 MED1 SKI NSUN2 LIN9 DDX1 LIG3 NCOR2 ANLN ZBTB21 TMF1 CTNNB1 TADA3 HCFC1 | 1.00e-05 | 992 | 135 | 20 | int:AR |
| Interaction | TERF2IP interactions | NCOA2 ERCC5 WDR70 ZMYND8 KDM3B MED1 THOC2 LIN9 LIG3 NCOR2 ANLN ZBTB21 HCFC1 SLX4 | 2.08e-05 | 552 | 135 | 14 | int:TERF2IP |
| Interaction | PCDHA6 interactions | 2.40e-05 | 9 | 135 | 3 | int:PCDHA6 | |
| Interaction | CEBPA interactions | NCOA2 TLK2 HYOU1 PHF12 CDKN2AIP ZMYND8 KDM3B C15orf39 EDC4 MED1 THOC2 NSUN2 LIN9 DDX1 LIG3 NCOR2 ANLN ZBTB21 BICRAL CTNNB1 TADA3 HCFC1 | 2.70e-05 | 1245 | 135 | 22 | int:CEBPA |
| Interaction | NR3C1 interactions | NCOA2 SP1 FAT4 HYOU1 CENPB ERCC6L PHF12 KDM3B NUP62 NUP214 MED1 POM121C LIG3 NCOR2 ANLN TMF1 MACROH2A2 CTNNB1 ARHGAP45 | 2.70e-05 | 974 | 135 | 19 | int:NR3C1 |
| Interaction | S100B interactions | 2.81e-05 | 179 | 135 | 8 | int:S100B | |
| Interaction | RBBP7 interactions | TLK2 SP1 TCOF1 PHF12 ZMYND8 TRIM31 SPAG9 BIRC6 LIN9 NCOR2 ANLN HCFC1 BAHCC1 | 3.71e-05 | 507 | 135 | 13 | int:RBBP7 |
| Interaction | PPARG interactions | 4.27e-05 | 307 | 135 | 10 | int:PPARG | |
| Interaction | YWHAH interactions | NCOA2 ERCC6L KDM3B NUP62 SPECC1L PLEKHG2 EDC4 MED1 PABIR2 DDX1 C6orf132 ARFGEF3 PTPN13 SLF2 ANLN AHNAK ZBTB21 NAV2 DCLRE1A UTRN | 4.52e-05 | 1102 | 135 | 20 | int:YWHAH |
| Interaction | RPA4 interactions | ERCC5 ERCC6L TCOF1 WDR70 NUP214 EDC4 ARFGEF3 LIG3 AHNAK SLTM HCFC1 SLX4 | 5.37e-05 | 452 | 135 | 12 | int:RPA4 |
| Interaction | FMR1 interactions | NCOA2 TCOF1 ZMYND8 TRIM31 ARHGEF18 EDC4 DDX1 NCOR2 SMG7 ANLN AHNAK MAP7D2 CTNNB1 | 6.55e-05 | 536 | 135 | 13 | int:FMR1 |
| Interaction | FBXO22 interactions | CDKN2AIP ZMYND8 SRCIN1 NUP214 NSUN7 NCOR2 TRANK1 NAV2 PHLPP1 MICAL3 ADGRF3 MUC4 HCFC1 | 7.06e-05 | 540 | 135 | 13 | int:FBXO22 |
| Interaction | CLP1 interactions | 8.67e-05 | 67 | 135 | 5 | int:CLP1 | |
| Interaction | NUP155 interactions | NUP62 NUP214 POM121C RTN1 CLCC1 FAM111B POM121 SLC30A5 ANLN PGRMC2 TMF1 SLX4 | 8.96e-05 | 477 | 135 | 12 | int:NUP155 |
| Interaction | GATA4 interactions | SP1 CDKN2AIP SRF MED1 LIN9 DDX1 LIG3 NCOR2 ZBTB21 SLTM MACROH2A2 | 1.03e-04 | 411 | 135 | 11 | int:GATA4 |
| Interaction | WWTR1 interactions | NCOA2 ERCC6L SPAG9 SPECC1L TEAD4 EDC4 PTPN13 SMG7 ANLN PGRMC2 HCFC1 | 1.30e-04 | 422 | 135 | 11 | int:WWTR1 |
| Interaction | RHBDF2 interactions | 1.40e-04 | 168 | 135 | 7 | int:RHBDF2 | |
| Interaction | RXRA interactions | 1.45e-04 | 169 | 135 | 7 | int:RXRA | |
| Interaction | GUSBP5 interactions | 1.48e-04 | 75 | 135 | 5 | int:GUSBP5 | |
| Interaction | TEAD4 interactions | 1.58e-04 | 76 | 135 | 5 | int:TEAD4 | |
| Interaction | CHD5 interactions | 1.68e-04 | 77 | 135 | 5 | int:CHD5 | |
| Interaction | SUMO2 interactions | SP1 SOBP ZMYND8 RNF213 NUP214 EDC4 NSUN2 DDX1 ANLN AHNAK ZBTB21 HCFC1 SLX4 | 1.73e-04 | 591 | 135 | 13 | int:SUMO2 |
| Interaction | MAPRE1 interactions | NUP62 NUP214 SPECC1L DNAJC6 NSUN2 PDE4DIP NAV3 NAV2 MAP7D2 CTNNB1 POM121B MTUS2 | 1.80e-04 | 514 | 135 | 12 | int:MAPRE1 |
| Interaction | KIF20A interactions | CENPB SPAG9 SPECC1L THOC2 NSUN2 DDX1 DES ANLN AHNAK NAV3 NAV2 PHLPP1 MAP7D2 MACROH2A2 ADGRF3 CTNNB1 SNAPC4 UTRN | 2.33e-04 | 1052 | 135 | 18 | int:KIF20A |
| Interaction | EYA4 interactions | 2.37e-04 | 243 | 135 | 8 | int:EYA4 | |
| Interaction | SIX4 interactions | 2.53e-04 | 46 | 135 | 4 | int:SIX4 | |
| Interaction | PIN1 interactions | 2.62e-04 | 383 | 135 | 10 | int:PIN1 | |
| Interaction | APC interactions | NUP214 SPECC1L POM121C ASAP1 PTPN13 POM121 NAV3 NAV2 PHLPP1 CTNNB1 | 2.96e-04 | 389 | 135 | 10 | int:APC |
| Interaction | HNF1B interactions | 2.97e-04 | 190 | 135 | 7 | int:HNF1B | |
| Interaction | TOP3B interactions | PITPNM2 HYOU1 PHF12 WDR70 KDM3B C15orf39 NUP214 EDC4 THOC2 POM121C BIRC6 C6orf132 LIG3 NCOR2 SMG7 RALGPS1 AHNAK NAV2 MICAL3 SNAPC4 HCFC1 BAHCC1 | 3.03e-04 | 1470 | 135 | 22 | int:TOP3B |
| Interaction | IFI16 interactions | SP1 CENPB DDX52 RNF213 NUP62 NUP214 EDC4 POM121C NSUN2 DDX1 LIG3 ANLN SLTM MACROH2A2 | 3.16e-04 | 714 | 135 | 14 | int:IFI16 |
| Interaction | CRX interactions | 3.19e-04 | 254 | 135 | 8 | int:CRX | |
| Interaction | ZBTB5 interactions | 3.23e-04 | 49 | 135 | 4 | int:ZBTB5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q11 | SPECC1L IGLV2-33 IGLV1-51 IGLV1-47 IGLV1-44 MICAL3 POM121L1P | 3.05e-04 | 419 | 139 | 7 | chr22q11 |
| Cytoband | 5q31 | 4.29e-04 | 115 | 139 | 4 | 5q31 | |
| Cytoband | 22q11.2 | 5.04e-04 | 120 | 139 | 4 | 22q11.2 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 7.56e-05 | 206 | 90 | 7 | 682 | |
| GeneFamily | NOP2/Sun RNA methyltransferase family | 5.06e-04 | 7 | 90 | 2 | 664 | |
| GeneFamily | Nucleoporins | 5.33e-04 | 32 | 90 | 3 | 1051 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 8.62e-04 | 9 | 90 | 2 | 755 | |
| GeneFamily | Immunoglobulin lambda locus at 22q11.2 | 1.02e-03 | 89 | 90 | 4 | 353 | |
| GeneFamily | ATP binding cassette subfamily B | 1.31e-03 | 11 | 90 | 2 | 806 | |
| GeneFamily | ATAC complex | 1.84e-03 | 13 | 90 | 2 | 1058 | |
| GeneFamily | Clustered protocadherins | 3.99e-03 | 64 | 90 | 3 | 20 | |
| GeneFamily | CD molecules|Mucins | 4.84e-03 | 21 | 90 | 2 | 648 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | FAT4 PDE1C SOBP SRRM4 SRCIN1 DNAJC6 RTN1 ADCY8 RALGPS1 PDE4DIP NAV3 MACROH2A2 BICRAL NIPA1 MTUS2 | 4.41e-07 | 584 | 137 | 15 | M39068 |
| Coexpression | WHITFIELD_CELL_CYCLE_S | 1.28e-06 | 150 | 137 | 8 | M2075 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | PITPNM2 ERCC5 SRF POM121C C6orf132 POM121 EFNB1 ABCB10 RALGPS1 AHNAK PDE4DIP ELAPOR1 POM121B UTRN | 7.88e-06 | 647 | 137 | 14 | MM981 |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP | 1.08e-05 | 200 | 137 | 8 | M7430 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.43e-05 | 208 | 137 | 8 | MM581 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | SOBP SRRM4 ZMYND8 MUC19 KIAA1549 SPOCK2 SRCIN1 DNAJC6 RTN1 ARFGEF3 RALGPS1 PDE4DIP NAV3 GOLGA8B MAP7D2 MICAL3 NIPA1 MTUS2 | 1.91e-05 | 1106 | 137 | 18 | M39071 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | SRRM4 MUC19 SRCIN1 DNAJC6 RTN1 ARFGEF3 RALGPS1 GOLGA8B MAP7D2 MACROH2A2 MTUS2 | 3.47e-05 | 465 | 137 | 11 | M39066 |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | PDE1C SRRM4 CNTNAP1 SRCIN1 CEP164 ARFGEF3 NCOR2 GOLGA8B OSBP2 SNAPC4 | 3.98e-05 | 389 | 137 | 10 | M39102 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA2 TLK2 ZMYND8 KDM3B SPAG9 SPECC1L MED1 THOC2 NCOR2 PTPN13 NAV3 PHLPP1 MICAL3 BICRAL MN1 | 4.35e-05 | 856 | 137 | 15 | M4500 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRN | SRRM4 SRCIN1 RTN1 ARFGEF3 PDE4DIP GOLGA8B MAP7D2 BICRAL MTUS2 | 6.99e-05 | 335 | 137 | 9 | M39065 |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_UP | 7.46e-05 | 194 | 137 | 7 | M9980 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | SOBP SRRM4 KIAA1549 SRCIN1 DNAJC6 RTN1 GOLGA8B MAP7D2 BICRAL NIPA1 MTUS2 | 8.37e-05 | 513 | 137 | 11 | M39069 |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN | 9.03e-05 | 200 | 137 | 7 | M8306 | |
| Coexpression | GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_DN | 9.03e-05 | 200 | 137 | 7 | M6556 | |
| Coexpression | GSE27786_LIN_NEG_VS_BCELL_DN | 9.03e-05 | 200 | 137 | 7 | M4768 | |
| Coexpression | GSE17721_LPS_VS_CPG_1H_BMDC_DN | 9.03e-05 | 200 | 137 | 7 | M3987 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | PITPNM2 ERCC5 SRF C6orf132 POM121 EFNB1 ABCB10 RALGPS1 AHNAK PDE4DIP ELAPOR1 UTRN | 9.11e-05 | 611 | 137 | 12 | M1106 |
| Coexpression | MARTENS_BOUND_BY_PML_RARA_FUSION | PITPNM2 RBBP8 PHF12 C15orf39 SKI NCOR2 PDE4DIP PLCB2 ARHGAP45 MN1 | 1.48e-04 | 456 | 137 | 10 | M2094 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 3.19e-07 | 186 | 135 | 10 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | TLK2 RBBP8 SOBP DDX52 SPOCK2 THOC2 LIN9 FNDC1 SLF2 SLTM TMF1 MAP7D2 MUC4 | 1.59e-05 | 492 | 135 | 13 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NCOA2 TLK2 TCOF1 SOBP SRRM4 ADGRV1 NSUN2 RTN1 LIN9 CLCC1 SMG7 PTPRZ1 ELAPOR1 SLTM NAV2 PHLPP1 MAP7D2 MICAL3 | 5.61e-05 | 989 | 135 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | ERCC5 ARHGEF18 TRANK1 SLF2 AHNAK GOLGA8B BICRAL CPLANE1 ARHGAP45 | 2.74e-09 | 167 | 138 | 9 | 948504367ecf58144d9dd74d2ec531358fc4b309 |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.27e-08 | 199 | 138 | 9 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-08 | 162 | 138 | 8 | 16f9fbcaa0093ffc5a2a5e32db6040e2cb519d47 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 1.28e-07 | 187 | 138 | 8 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.15e-07 | 200 | 138 | 8 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.39e-07 | 144 | 138 | 7 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-06 | 177 | 138 | 7 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-06 | 177 | 138 | 7 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.36e-06 | 177 | 138 | 7 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.36e-06 | 177 | 138 | 7 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.36e-06 | 177 | 138 | 7 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 1.70e-06 | 183 | 138 | 7 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 184 | 138 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 184 | 138 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 184 | 138 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.10e-06 | 189 | 138 | 7 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 2.10e-06 | 189 | 138 | 7 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-06 | 189 | 138 | 7 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-06 | 189 | 138 | 7 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.34e-06 | 192 | 138 | 7 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.42e-06 | 193 | 138 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Airway-Club|LPS_only / Treatment groups by lineage, cell group, cell type | 2.96e-06 | 199 | 138 | 7 | 165ac94b2d56072ad43358b5127d77555221e2d8 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.06e-06 | 200 | 138 | 7 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.06e-06 | 200 | 138 | 7 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 9.64e-06 | 157 | 138 | 6 | d4da4057917dda066da0f2aac2621fdaf1fb943b | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 161 | 138 | 6 | 140b3c7077947c541cff54f6754e2df968345f4d | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 167 | 138 | 6 | a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 168 | 138 | 6 | 2e88d9cb7c80a4656fab290db8b45a5a0599d769 | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.52e-05 | 170 | 138 | 6 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | 367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-05 | 173 | 138 | 6 | c2d973356c40e0284fd3bd7733a164b141c66008 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-05 | 173 | 138 | 6 | d8e965ff7e9b758876ec1521c1ccedd739e8d673 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-05 | 174 | 138 | 6 | 271c51d220842402975d97c86c9acfdbdf62a32c | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.97e-05 | 178 | 138 | 6 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.09e-05 | 180 | 138 | 6 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 2.16e-05 | 181 | 138 | 6 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 2.44e-05 | 185 | 138 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.44e-05 | 185 | 138 | 6 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.52e-05 | 186 | 138 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.67e-05 | 188 | 138 | 6 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 2.84e-05 | 190 | 138 | 6 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 2.84e-05 | 190 | 138 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-05 | 191 | 138 | 6 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-05 | 191 | 138 | 6 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 192 | 138 | 6 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 3.01e-05 | 192 | 138 | 6 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 192 | 138 | 6 | d766221acfce30cbf2c60b3ae40f6744968b952c | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 3.10e-05 | 193 | 138 | 6 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | facs-Trachea-24m-Epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.10e-05 | 193 | 138 | 6 | ec49a83b24371579d4ad46aad91c25115aa226f9 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.19e-05 | 194 | 138 | 6 | 3701ca87c6dc9ccd7b4146e56371546174d26c36 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.19e-05 | 194 | 138 | 6 | 65f9bf126be26114c2c3f4c46d48318986212a92 | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.19e-05 | 194 | 138 | 6 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.19e-05 | 194 | 138 | 6 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 195 | 138 | 6 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.28e-05 | 195 | 138 | 6 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 3.57e-05 | 198 | 138 | 6 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.57e-05 | 198 | 138 | 6 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 3.57e-05 | 198 | 138 | 6 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 3.57e-05 | 198 | 138 | 6 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Slc17a8|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.62e-05 | 60 | 138 | 4 | 40f29dfdbb17d39d8e6bb69dc5066fca3cd03308 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Slc17a8-Inhibitory_Neuron.Gad1Gad2Slc17a8_Sst.Ncam2_(Interneuron,__GABA/Glutamate_co-releasing?)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.62e-05 | 60 | 138 | 4 | 3a58f7a8e3d8a544286b7a3fe62efac8a0a0bb11 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Slc17a8-Inhibitory_Neuron.Gad1Gad2Slc17a8_Sst.Ncam2_(Interneuron,__GABA/Glutamate_co-releasing?)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.62e-05 | 60 | 138 | 4 | ce13bbda7d105e1cb421790fb50d3b55ba2ed09a | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Airway-Club|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.67e-05 | 199 | 138 | 6 | 8649c2380285a668782d75eb076ce548eed0911d | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.78e-05 | 200 | 138 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.78e-05 | 200 | 138 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.78e-05 | 200 | 138 | 6 | 7c2d499af60654b7b28f172ac2c914ad49fb74b4 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.14e-05 | 134 | 138 | 5 | 72d7eec3aeb43319f3ef81bb5518fae8d8880136 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasmablast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.16e-05 | 76 | 138 | 4 | df1c29cf88b1957e210058e172683f78a1eea2bd | |
| ToppCell | Dendritic_Cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.08e-04 | 151 | 138 | 5 | e089bf197ed60e7243160521d4390d4b40a3832b | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.11e-04 | 152 | 138 | 5 | 1b2a39ae159e79f1fb18d6d164bd7acab5299fca | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.26e-04 | 156 | 138 | 5 | 8790b4b400695571fcf1ccb24c658b5e90854ff7 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Club|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.33e-04 | 158 | 138 | 5 | 03281e87780e3bacd089903383c016d03c373bf7 | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-04 | 158 | 138 | 5 | 50df52d64d07178975563abd98ce4fddb9f2f7ef | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 160 | 138 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | Severe-Lymphoid-NK-Proliferating_T|Severe / Condition, Lineage, Cell class and cell subclass | 1.41e-04 | 160 | 138 | 5 | cb2276d9bd78508644420e9580d3c17b914224cb | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-04 | 160 | 138 | 5 | af84da18c85037f49f55e8958f00f12140226982 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.41e-04 | 160 | 138 | 5 | 79e833c904c762434993b5ec9d5e3540e695fad3 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-04 | 160 | 138 | 5 | f7ca98beaa24f9674d503588eb15d341c4135d77 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-04 | 160 | 138 | 5 | a76ad44b5f25f59d6b9333fb45f8bb96196a3090 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 160 | 138 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-04 | 161 | 138 | 5 | a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-04 | 161 | 138 | 5 | 08920a716f6ec62538e361211455a30ad726d7be | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.50e-04 | 162 | 138 | 5 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 163 | 138 | 5 | 99cf60dc87f7ce288553091bffcd85109a02bd8f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 163 | 138 | 5 | 510c0af66e82c5a8cf8edd0547dae4018a87dbbf | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-04 | 165 | 138 | 5 | 3d2acdae0dd2b79a15f74158e8e566ce22b4218e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.68e-04 | 166 | 138 | 5 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.68e-04 | 166 | 138 | 5 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.68e-04 | 166 | 138 | 5 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | Basal_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.68e-04 | 166 | 138 | 5 | aea2ae12e4746149ebc6da063ef694381c098f80 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.73e-04 | 167 | 138 | 5 | dbd2b9f2f4ba7be5fdf8318094e6b078cb1d1c43 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.78e-04 | 168 | 138 | 5 | 6a233045638cb83dab64789b996b7598c325001e | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-04 | 168 | 138 | 5 | ce5e92a1df3acfa5cd8d5a134e4af231dc592a13 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-04 | 168 | 138 | 5 | 22c89d4eb44573f6301069ec7ca7cbd0dd958403 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.88e-04 | 170 | 138 | 5 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 171 | 138 | 5 | 872b3b33cd3893d63c45617db0269692430b0e8b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 172 | 138 | 5 | 3ffe721f62c0d20c1d765ecb15ed4e1aa88099f7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 172 | 138 | 5 | 2bbe3f601a56577d200aa7ba7031f7c19b988cc1 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 173 | 138 | 5 | 3059325901b1e5e12a1a91183f14267288b2f600 | |
| ToppCell | facs-Heart-RA-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 173 | 138 | 5 | 49030c2dd04b592655df1a667e2f90efb499e0a5 | |
| ToppCell | facs-Heart-RA-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 173 | 138 | 5 | 1cfbab6603f8baf8e238837bb72740c43a7dc0ec | |
| Drug | N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; PC3; HT_HG-U133A | DDN NUP214 HOXA6 DES NCOR2 DCLRE1A SNAPC4 CPLANE1 MN1 PLXNB1 | 2.89e-07 | 197 | 135 | 10 | 6732_DN |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 3.02e-07 | 198 | 135 | 10 | 1479_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.25e-06 | 179 | 135 | 9 | 2105_DN | |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A | 2.65e-06 | 196 | 135 | 9 | 6994_DN | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 10uM; PC3; HT_HG-U133A | 2.77e-06 | 197 | 135 | 9 | 4557_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 8.11e-06 | 170 | 135 | 8 | 3791_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 9.22e-06 | 173 | 135 | 8 | 5950_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.09e-05 | 177 | 135 | 8 | 7047_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.18e-05 | 179 | 135 | 8 | 5822_DN | |
| Drug | scriptaid; Down 200; 10uM; PC3; HT_HG-U133A | 1.33e-05 | 182 | 135 | 8 | 6896_DN | |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Up 200; 16uM; PC3; HT_HG-U133A | 2.28e-05 | 196 | 135 | 8 | 4564_UP | |
| Drug | Tenoxicam [59804-37-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.36e-05 | 197 | 135 | 8 | 2860_DN | |
| Drug | Flurbiprofen [5104-49-4]; Down 200; 16.4uM; PC3; HT_HG-U133A | 2.36e-05 | 197 | 135 | 8 | 4674_DN | |
| Drug | Norethynodrel [68-23-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.45e-05 | 198 | 135 | 8 | 7471_UP | |
| Drug | Bromopride [4093-35-0]; Up 200; 11.6uM; PC3; HT_HG-U133A | 2.45e-05 | 198 | 135 | 8 | 4278_UP | |
| Drug | Etoposide [33419-42-0]; Down 200; 6.8uM; PC3; HT_HG-U133A | 2.45e-05 | 198 | 135 | 8 | 6681_DN | |
| Drug | Chlorthalidone [77-36-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.45e-05 | 198 | 135 | 8 | 6800_UP | |
| Drug | Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 2.45e-05 | 198 | 135 | 8 | 3223_UP | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 2.45e-05 | 198 | 135 | 8 | 7519_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 8.22e-05 | 174 | 135 | 7 | 5745_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 8.52e-05 | 175 | 135 | 7 | 4072_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 8.83e-05 | 176 | 135 | 7 | 1212_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A | 9.81e-05 | 179 | 135 | 7 | 1175_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.02e-04 | 180 | 135 | 7 | 3688_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.02e-04 | 180 | 135 | 7 | 6886_DN | |
| Drug | Rifabutin [72559-06-9]; Down 200; 4.8uM; PC3; HT_HG-U133A | 1.13e-04 | 183 | 135 | 7 | 4527_DN | |
| Drug | retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A | 1.20e-04 | 185 | 135 | 7 | 6931_UP | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 1.25e-04 | 186 | 135 | 7 | 6996_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 10000uM; HL60; HG-U133A | 1.38e-04 | 189 | 135 | 7 | 410_DN | |
| Drug | Beclomethasone dipropionate [5534-09-8]; Up 200; 7.6uM; PC3; HT_HG-U133A | 1.47e-04 | 191 | 135 | 7 | 4580_UP | |
| Drug | 5707885; Down 200; 50uM; PC3; HT_HG-U133A | 1.52e-04 | 192 | 135 | 7 | 6438_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A | 1.52e-04 | 192 | 135 | 7 | 1971_DN | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 10uM; PC3; HT_HG-U133A | 1.57e-04 | 193 | 135 | 7 | 4289_UP | |
| Drug | CGX 0596987; Down 200; 20uM; PC3; HT_HG-U133A | 1.62e-04 | 194 | 135 | 7 | 6417_DN | |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 1.62e-04 | 194 | 135 | 7 | 4662_DN | |
| Drug | SC-560; Up 200; 10uM; MCF7; HT_HG-U133A | 1.67e-04 | 195 | 135 | 7 | 6913_UP | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 1uM; PC3; HT_HG-U133A | 1.67e-04 | 195 | 135 | 7 | 4333_DN | |
| Drug | valinomycin; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.67e-04 | 195 | 135 | 7 | 5911_DN | |
| Drug | CP-645525-01 [287190-82-3]; Down 200; 10uM; PC3; HT_HG-U133A | 1.72e-04 | 196 | 135 | 7 | 7527_DN | |
| Drug | Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.72e-04 | 196 | 135 | 7 | 7269_UP | |
| Drug | Bemegride [64-65-3]; Down 200; 25.8uM; MCF7; HT_HG-U133A | 1.72e-04 | 196 | 135 | 7 | 3389_DN | |
| Drug | Ketoconazole [65277-42-1]; Down 200; 7.6uM; PC3; HT_HG-U133A | 1.72e-04 | 196 | 135 | 7 | 4624_DN | |
| Drug | Torsemide [56211-40-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.72e-04 | 196 | 135 | 7 | 3517_DN | |
| Drug | Azaperone [1649-18-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 135 | 7 | 3573_DN | |
| Drug | Disopyramide [3737-09-5]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.78e-04 | 197 | 135 | 7 | 7276_DN | |
| Drug | SB 203580; Down 200; 1uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 135 | 7 | 7061_DN | |
| Drug | Benzthiazide [91-33-8]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.78e-04 | 197 | 135 | 7 | 6607_DN | |
| Drug | PNU-0293363 [326823-19-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 135 | 7 | 6573_DN | |
| Drug | Reserpinic acid hydrochloride; Down 200; 9.2uM; HL60; HT_HG-U133A | 1.78e-04 | 197 | 135 | 7 | 2903_DN | |
| Drug | Promethazine hydrochloride [58-33-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 135 | 7 | 5317_UP | |
| Drug | Captopril [62571-86-2]; Up 200; 17.2uM; PC3; HT_HG-U133A | 1.78e-04 | 197 | 135 | 7 | 4585_UP | |
| Drug | Deoxycorticosterone [64-85-7]; Down 200; 12.2uM; PC3; HT_HG-U133A | 1.78e-04 | 197 | 135 | 7 | 6758_DN | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; PC3; HT_HG-U133A | 1.78e-04 | 197 | 135 | 7 | 6663_DN | |
| Drug | Viomycin sulfate [37883-00-4]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 135 | 7 | 7036_UP | |
| Drug | Oxaprozin [21256-18-8]; Down 200; 13.6uM; PC3; HT_HG-U133A | 1.78e-04 | 197 | 135 | 7 | 4530_DN | |
| Drug | Procarbazine hydrochloride [366-70-1]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 135 | 7 | 5452_DN | |
| Drug | Acebutolol hydrochloride [34381-68-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 135 | 7 | 4976_DN | |
| Drug | Flunixin meglumine [42461-84-7]; Up 200; 8.2uM; PC3; HT_HG-U133A | 1.83e-04 | 198 | 135 | 7 | 3713_UP | |
| Drug | PF-00539758-00 [351321-34-1]; Down 200; 10uM; PC3; HT_HG-U133A | 1.83e-04 | 198 | 135 | 7 | 6421_DN | |
| Drug | Delsoline [509-18-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.89e-04 | 199 | 135 | 7 | 7212_DN | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 1uM; PC3; HT_HG-U133A | 1.89e-04 | 199 | 135 | 7 | 4561_DN | |
| Drug | Tropine [120-29-6]; Up 200; 28.4uM; MCF7; HT_HG-U133A | 1.89e-04 | 199 | 135 | 7 | 3569_UP | |
| Drug | Sulfabenzamide [127-71-9]; Down 200; 14.4uM; PC3; HT_HG-U133A | 1.89e-04 | 199 | 135 | 7 | 6634_DN | |
| Drug | Sulpiride [15676-16-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.89e-04 | 199 | 135 | 7 | 4389_UP | |
| Drug | Suxibuzone [27470-51-5]; Up 200; 9.2uM; HL60; HT_HG-U133A | 1.95e-04 | 200 | 135 | 7 | 2503_UP | |
| Drug | Tiabendazole [148-79-8]; Up 200; 19.8uM; PC3; HT_HG-U133A | 1.95e-04 | 200 | 135 | 7 | 4579_UP | |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.95e-04 | 200 | 135 | 7 | 3577_DN | |
| Drug | TYB1 | 2.08e-04 | 4 | 135 | 2 | CID006478493 | |
| Drug | 1,25(OH)2-16-ene-23-yne-26,27-hexafluoro-19-nor-D3 | 2.08e-04 | 4 | 135 | 2 | ctd:C408047 | |
| Disease | sleep efficiency | 1.97e-04 | 5 | 132 | 2 | EFO_0803364 | |
| Disease | stimulant use measurement | 2.64e-04 | 28 | 132 | 3 | EFO_0600076 | |
| Disease | 1,5 anhydroglucitol measurement | 2.94e-04 | 29 | 132 | 3 | EFO_0008009 | |
| Disease | osteoporosis | 3.28e-04 | 73 | 132 | 4 | EFO_0003882 | |
| Disease | neutrophil count, basophil count | 5.29e-04 | 224 | 132 | 6 | EFO_0004833, EFO_0005090 | |
| Disease | serum gamma-glutamyl transferase measurement | SPECC1L SKI POM121C NCOR2 TRANK1 POM121 AHNAK NAV2 ABCB11 MICAL3 ALPK2 BAHCC1 | 8.46e-04 | 914 | 132 | 12 | EFO_0004532 |
| Disease | primary biliary cholangitis (is_implicated_in) | 8.73e-04 | 10 | 132 | 2 | DOID:12236 (is_implicated_in) | |
| Disease | severe acute respiratory syndrome, COVID-19 | 9.35e-04 | 447 | 132 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | response to antineoplastic agent | 1.04e-03 | 99 | 132 | 4 | GO_0097327 | |
| Disease | left ventricular diastolic function measurement | 1.84e-03 | 54 | 132 | 3 | EFO_0008204 | |
| Disease | respiratory symptom change measurement, response to placebo | 2.58e-03 | 17 | 132 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | Fetal Alcohol Syndrome | 2.58e-03 | 17 | 132 | 2 | C0015923 | |
| Disease | Malignant Neoplasms | 2.66e-03 | 128 | 132 | 4 | C0006826 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 2.66e-03 | 128 | 132 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 2.66e-03 | 128 | 132 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 2.66e-03 | 128 | 132 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 2.66e-03 | 128 | 132 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 2.66e-03 | 128 | 132 | 4 | C0007134 | |
| Disease | magnesium measurement | 3.26e-03 | 66 | 132 | 3 | EFO_0004845 | |
| Disease | Benign Neoplasm | 3.55e-03 | 68 | 132 | 3 | C0086692 | |
| Disease | Neoplasms | 3.55e-03 | 68 | 132 | 3 | C0027651 | |
| Disease | Craniosynostosis | 3.58e-03 | 20 | 132 | 2 | C0010278 | |
| Disease | vital capacity | RBBP8 WDR70 PCDHA10 PCDHA8 PCDHA6 MED1 SKI ADCY8 NCOR2 MICAL3 SNAPC4 UTRN PDZD2 | 3.69e-03 | 1236 | 132 | 13 | EFO_0004312 |
| Disease | Primary microcephaly | 4.33e-03 | 22 | 132 | 2 | C0431350 | |
| Disease | Hepatitis | 4.33e-03 | 22 | 132 | 2 | HP_0012115 | |
| Disease | Takayasu arteritis | 4.47e-03 | 148 | 132 | 4 | EFO_1001857 | |
| Disease | attention function measurement | 4.47e-03 | 148 | 132 | 4 | EFO_0007636 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 4.47e-03 | 148 | 132 | 4 | C0279702 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SGKESGADGASTSPR | 286 | O75528 | |
| TKVFPERSGSGSASG | 106 | P40145 | |
| LASAPTGSGKTLAFS | 206 | Q9Y2R4 | |
| AELLTSGAKSPTGAS | 2101 | Q9P281 | |
| TGAGSGPSSSSKSKL | 2431 | Q9P281 | |
| SPGEGSKASSFNESG | 371 | Q8IZF5 | |
| ADSPSEGFSLKAGGT | 1316 | Q6ZSZ5 | |
| SGKTSGNFTIDPDGS | 591 | P78357 | |
| DGSLSKGIEPSSEGS | 981 | Q9NR09 | |
| SSPVFGATSSIKSGL | 326 | Q99708 | |
| KSTSSESGGVSSPGK | 1486 | Q8N7X0 | |
| GKSPGTLTAVTGSEE | 1696 | Q86TB3 | |
| EDGPGDGFTILSSKS | 176 | Q9P0M6 | |
| ATDSGSPALTGTGTI | 2336 | Q6V0I7 | |
| GDGKLGSTPTSGASI | 1671 | Q8WXG9 | |
| SSSASTGGKLVKPGT | 31 | Q69YQ0 | |
| SVTALVGPSGSGKST | 521 | Q9NRK6 | |
| TALVGPSGAGKSTAL | 451 | O95342 | |
| GGVTGSPEASISGSK | 5726 | Q09666 | |
| PGGLQLKAGSESASS | 481 | Q86WK7 | |
| KATGSAGTEIAPAGS | 336 | O94850 | |
| KLGERTSSSFSPGDS | 421 | Q5JR59 | |
| LAVEDTGGPSASAGK | 31 | Q9BTK6 | |
| VSSKEDLAGPSAGSG | 296 | Q5JS13 | |
| ASLASASGGFGTKVP | 886 | Q6P2E9 | |
| FLTATDGGKPELTGT | 211 | Q9UN73 | |
| SSSSGTDLTGDKAGP | 1241 | O60271 | |
| TSTGAATGGPLDSTL | 886 | Q9HCM3 | |
| TDPSKLESPSFTGTG | 466 | Q08J23 | |
| ASGAGTKPTILGISS | 741 | P51610 | |
| DATLGPSGGTSLSKT | 721 | Q99102 | |
| ESLKSRPGTASSSGG | 1506 | Q9Y618 | |
| HSGATTTAPSLSGKG | 36 | P35222 | |
| FLTATDGGKPELTGT | 211 | Q9Y5H6 | |
| GPDGSFTSSEGSSGK | 1681 | Q7RTP6 | |
| AGSAPGAGSTATKTL | 431 | Q92619 | |
| SDKDLSGASPSGSGK | 81 | P31267 | |
| KISGSDTETLGGFPV | 326 | Q5TKA1 | |
| ALGKPTAGTTDAGEA | 386 | Q96T17 | |
| PSGISDLFSGSKSGN | 76 | A0A075B6J2 | |
| SQSKDKSTTPGGTGI | 356 | Q9NQW6 | |
| GTKTSASKTGIPGSS | 4106 | Q2LD37 | |
| GFDSVPLKTSSGGLD | 996 | Q6UXG2 | |
| SGSPKKSALEGSSAS | 266 | Q9NXV6 | |
| AETGSGKTGAFSIPV | 46 | Q92499 | |
| GSSGLTSTDALPGVT | 111 | Q8IWD5 | |
| SAGPTKSFLSGGREI | 1256 | O43157 | |
| SGVPDRFSGSKSGTS | 76 | P01700 | |
| SGIPDRFSGSKSGTS | 76 | P01701 | |
| TEGLEKTGPSITGSG | 3091 | Q7Z5P9 | |
| TGPSAEVTGKTGLSA | 3686 | Q7Z5P9 | |
| TTGPSAEATGKTGLS | 6011 | Q7Z5P9 | |
| AKSGTSIPSAGKTGT | 6086 | Q7Z5P9 | |
| ATTGAFSGKTLEPGN | 6516 | Q7Z5P9 | |
| SGVKTSGSEGSAPIN | 481 | Q14123 | |
| SDEGSSSSLGRKTPG | 706 | O15018 | |
| SSSDLISSPGKKGAA | 1231 | O15018 | |
| GDVKLGTLGSGSESS | 6 | O15173 | |
| TGTKSTLPISETGGG | 876 | P07202 | |
| GSSLQRSPSDAGKSS | 1031 | Q8IVL0 | |
| SGVPDRFSGSKSGTS | 76 | P01699 | |
| GTDTKPGSKAGSSVD | 576 | Q7LBC6 | |
| TKESSQPDAFSSGGG | 1246 | P35658 | |
| PAASSSLAAKASLGG | 256 | Q86UU5 | |
| FSLKAPGAASGTSTT | 256 | P37198 | |
| GSEFSGKGDVPNTSL | 486 | P23471 | |
| GGTILDTGAGDPSSK | 431 | Q9BZ72 | |
| GSSTTGGSSEENKGP | 846 | P49916 | |
| SSGVGAGPFTKAASE | 111 | Q969R2 | |
| GSSSSSGLSSDPLAK | 206 | Q7Z309 | |
| SGLSSDPLAKGSATA | 211 | Q7Z309 | |
| LTATDGGKPEFTGSV | 211 | Q9Y5I2 | |
| GSTTESKPVFGGTAT | 1146 | A8CG34 | |
| GSTTESKPVFGGTAT | 751 | A6NF01 | |
| APSFSIGAGSKTLGA | 806 | A6NF01 | |
| EATGFLPAAGEKTSG | 96 | P83859 | |
| ALSFSIGAGSKTPGA | 1221 | Q96HA1 | |
| GVPEKSLGGSSLTET | 526 | Q5T0Z8 | |
| GGPNATITTSLKSEG | 391 | P07199 | |
| ISSLFGGGTTPDAKE | 581 | Q9Y4L1 | |
| GLLSTTLPGQDSGSK | 641 | Q6AI39 | |
| SKSDAGGSVAVATPG | 1826 | Q9H799 | |
| SSTPRGGKDADGSLA | 1206 | Q4ZHG4 | |
| ESSTPSTGGFSGKET | 1946 | Q5TH69 | |
| PRAGFGSKGSSSSVT | 36 | P17661 | |
| SLSTLASPKGGSGTA | 281 | P98172 | |
| DLGTLGSSSFASKPT | 681 | O75061 | |
| GGPSSSSKTTNKFEG | 861 | Q9ULH1 | |
| GGSKTSSTIKSTPSG | 301 | P33241 | |
| SPASGGSFSETKSGV | 191 | Q6PJP8 | |
| SGNKTDKDTPGITGS | 5566 | Q8NDH2 | |
| LSGKSRFSGAGASTP | 201 | Q1W209 | |
| TKANGSSPETAASGG | 36 | A8MQT2 | |
| SDGSSGSPVFNASGK | 646 | Q6SJ93 | |
| PASTKTGQAGSLSGS | 476 | Q9ULU4 | |
| SASIGGTATLTGTAP | 241 | Q8WWT9 | |
| SSGTSLLPKDGAPFS | 11 | Q96BU1 | |
| SLLGSFTVPSTKGIG | 196 | Q7RTP0 | |
| VLSGDSGKATEGPFA | 56 | O75309 | |
| SSGLGSSGSLSQKTP | 1246 | Q15648 | |
| DGKGTGSADSIATLP | 801 | Q2NKX8 | |
| GSADSIATLPKGFGS | 806 | Q2NKX8 | |
| SLATGASGLPAVSKA | 266 | Q3SYA9 | |
| GKGLPTGRSSTSDVL | 206 | Q12923 | |
| ISSSYSSTGGLPGLK | 81 | A6NNC1 | |
| GSLDGGAKSDSSSPN | 1026 | Q10571 | |
| SGTEPSAAESQGKGS | 336 | Q16799 | |
| EGLTGTSLPKERGST | 71 | P46939 | |
| NKTSEPGSSSAGGRT | 331 | Q9BZY9 | |
| LSPKTGGKEAASGTT | 1256 | Q13428 | |
| SGTGAAGASDTTIKP | 1216 | P0DJD1 | |
| QLTSLPLSGGKSSAG | 21 | Q8NE18 | |
| AADGSPGLKSVLSTS | 516 | Q92540 | |
| DGKGIPFTATLASSS | 436 | P28715 | |
| SSSLASSEGKGPGGT | 636 | Q8IVL1 | |
| SDGKVSPGTLSIGSA | 696 | Q96QT6 | |
| DTLKKGPSSTGASGQ | 336 | Q9NWH9 | |
| ADSNVSSGKISGGPL | 531 | Q8IX21 | |
| GSEGSGTATPSALIT | 731 | P08047 | |
| DGSSGLGISSPKEFS | 116 | Q9NX31 | |
| SSSSAKDLGSPGARA | 506 | P12755 | |
| SSANGTVLKSTGSGP | 316 | P11831 | |
| KSSGAGSLGNSRPSF | 1491 | Q8IY92 | |
| TGVGVSKGPLNSESS | 21 | Q86UE8 | |
| SPGADSSLSSAVGKG | 286 | Q9UPV0 | |
| GGDQALSKSTGSPTE | 116 | Q7L1S5 | |
| GILGEGTPKESSTES | 476 | Q96S66 | |
| LRGVPAEGSSKDSSG | 191 | Q6ZRI6 | |
| GDKSGSAGAPSKNSS | 26 | Q9H7T3 | |
| SLPGSGSTHGTSLKE | 671 | Q15596 | |
| SKGGSSEPGTELQTT | 246 | Q63HN8 | |
| GETLAAGTSSPKTEG | 161 | P82094 | |
| SKLGLVIPSSGSGSG | 311 | Q9ULJ3 | |
| GGPSSSSIGSASKSD | 1206 | Q8NI27 | |
| STAGLTEDSGSQKGP | 856 | A0A1B0GUW6 | |
| KDSGSSSVFAESPGG | 511 | Q9C0H9 | |
| ESPGGKTRSAGSAST | 521 | Q9C0H9 | |
| KFGGSSPLRDSTTLG | 26 | Q8TDD2 | |
| ATGNGLSDSPAGSKD | 106 | A7XYQ1 | |
| QGEAGKGASLPSSAS | 751 | Q9H6E5 | |
| GTKTVSALGLDPSGA | 181 | Q9NW82 | |
| SPSGGLSKSRELNSG | 311 | A7MD48 | |
| GSTASGGSQALDKPI | 21 | Q15561 | |
| QFSGPTSSSKDTGGE | 466 | Q00722 | |
| LSVLFTSSGGGPAKT | 136 | Q8TAD4 | |
| DPGGSFTLTSANVGK | 1276 | O60346 | |
| PKGSSASQGGSKEAS | 601 | Q5SXM2 | |
| GSGKAGAPSSERTAS | 801 | Q9H7P9 | |
| SKDLSGFSNGDGPTS | 311 | O15050 | |
| GSASSVAGPASGLDK | 226 | Q92563 | |
| STLSSKGGSEGQPES | 371 | Q9P206 | |
| PQKGSVSGDLSSGSS | 1816 | Q5VU43 |